A detailed history of Icon Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 37,989 shares of ABBV stock, worth $6.67 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
37,989
Previous 42,941 11.53%
Holding current value
$6.67 Million
Previous $5.79 Million 2.13%
% of portfolio
0.64%
Previous 0.61%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $661,537 - $765,826
-4,952 Reduced 11.53%
37,989 $5.66 Million
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $551,904 - $686,808
-4,165 Reduced 8.84%
42,941 $5.79 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $513,365 - $591,217
-3,550 Reduced 7.01%
47,106 $7.51 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $103,627 - $131,744
-753 Reduced 1.46%
50,656 $7.76 Million
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $718,895 - $891,946
5,447 Added 11.85%
51,409 $8.33 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $255,361 - $323,105
-2,377 Reduced 4.92%
45,962 $6.22 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $62,882 - $71,380
-591 Reduced 1.21%
48,339 $5.21 Million
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $353,821 - $394,177
3,363 Added 7.38%
48,930 $5.51 Million
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $907,707 - $999,277
8,873 Added 24.18%
45,567 $4.93 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $522,863 - $705,920
6,496 Added 21.51%
36,694 $3.93 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $594,325 - $697,541
6,918 Added 29.72%
30,198 $2.65 Million
Q2 2020

Jul 14, 2020

BUY
$73.37 - $98.18 $1.41 Million - $1.89 Million
19,247 Added 477.24%
23,280 $2.29 Million
Q1 2020

Apr 17, 2020

BUY
$64.5 - $97.79 $1,741 - $2,640
27 Added 0.67%
4,033 $307,000
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $22,360 - $27,977
310 Added 8.39%
4,006 $355,000
Q3 2019

Oct 24, 2019

SELL
$62.98 - $75.72 $7,557 - $9,086
-120 Reduced 3.14%
3,696 $280,000
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $328 - $419
-5 Reduced 0.13%
3,816 $277,000
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $117,175 - $137,910
-1,519 Reduced 28.45%
3,821 $308,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $152,430 - $187,987
1,958 Added 57.89%
5,340 $492,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $50,856 - $56,536
572 Added 20.36%
3,382 $320,000
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $10,504 - $12,428
-117 Reduced 4.0%
2,810 $260,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $55,758 - $74,665
-606 Reduced 17.15%
2,927 $277,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $316,415 - $346,975
3,533
3,533 $342,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.